Market Analysis and Insights: Global Heart Pump Device Market
In 2020, the global Heart Pump Device market size was US$ 1054 million and it is expected to reach US$ 2107.6 million by the end of 2027, with a CAGR of 10.3% between 2021 and 2027
Global Heart Pump Device Scope and Market Size
The global Heart Pump Device market is segmented by region (country), company, by Type, and by Application. Players, stakeholders, and other participants in the global Heart Pump Device market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.

Segment by Type
Ventricular Assist Devices (VADs)
Intra-aortic Balloon Pumps (IABPs)
Total Artificial Heart (TAH)

Segment by Application
Bridge-to-Transplant (BTT)
Bridge-to-Candidacy (BTC)
Destination Therapy (DT)
Others

By Company
St. Jude Medical (subsidiary of Abbott Laboratories) (US)
Abiomed (US)
Medtronic (Ireland)
Getinge (Sweden)
Teleflex (US)
ReliantHeart (US)
BerlinHeart (Germany)
Terumo (Japan)
SynCardia Systems (US)
TandemLife (CardiacAssist) (US)
Jarvik Heart (US)
Fresenius Medical Care (Germany)

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Colombia
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE